Spyre Therapeutics (NASDAQ:SYRE) Releases Earnings Results, Beats Expectations By $0.53 EPS
Spyre Therapeutics (NASDAQ:SYRE - Get Free Report) released its earnings results on Tuesday. The company reported ($0.15) earnings per share for the quarter, beating the consensus estimate of ($0.73) by $0.58.


Market Beat
